Crestor, containing rosuvastatin calcium, is a medication commonly prescribed to reduce the risk of heart attack and stroke, as well as to improve cholesterol levels in individuals with high cholesterol.
The drug’s patent expired in 2014, allowing for more affordable generic versions. However, its price is generally not as effective as some branded versions, making it difficult to access the drug without a doctor’s prescription. In India, the price of the drug in some cases can range from around Rs. 550 (Rajiv Soma) to Rs. 1,000 (Shreeveh Choudhary) depending on the manufacturer.
The generic version of Crestor, which is also sold under the name Crestor, is priced at a lower price. However, it is still not covered by most insurance plans, with some patients paying only a fraction of the price of the branded version.
The cost of the drug varies depending on the manufacturer, but is typically much lower. A few individuals may opt to pay up to Rs. 5000 (Rajiv Soma) for a 30-day supply, while many more patients may require a lower price.
When looking for a cheaper alternative to Crestor, there are several options available to help patients save money on their prescriptions. One such option is the free generic version of Lipitor (atorvastatin) that is available in India. This can be significantly cheaper than the branded version and offers similar benefits.
Another option is the branded version of Lipitor. The generic version is usually cheaper than the branded version, though it may still cost a fraction of the price.
In summary, the cost of Crestor, including its generic version, can vary based on several factors, including the manufacturer and its location in India. As with any medication, there are potential risks involved, such as the risk of a heart attack or stroke, which can be serious, especially when taken with other medications. It’s important to talk to your doctor before starting any new medication, especially if you’re already taking other drugs to manage your health conditions.
If you have a heart condition and are taking any other medications, be sure to tell your doctor about all the medications you are currently taking. This will help them determine whether or not you are at risk of experiencing side effects from taking this medication.
| |Many people take Crestor to manage their cholesterol levels. This includes taking Crestor to lower their blood pressure and to reduce their risk of certain heart conditions such as high blood pressure. Some people also take statins such as atorvastatin and simvastatin to lower their cholesterol levels. Additionally, some people take statins to treat certain types of cholesterol conditions. The dosage and duration of Crestor treatment depends on the type of cholesterol condition it is being used to treat and other factors that affect cholesterol levels.
In India, there is a range of options for Crestor. Some individuals may choose to stop using Crestor after a consultation with their doctor, while others may start taking the medication after consulting their doctor. Some people may also decide to continue taking the medication for a longer period of time, while others may stop taking the medication.
For some individuals, the cost of Crestor may be more affordable than in many other countries. Some patients may be able to purchase a generic version of the medication. However, this option may not be covered by most insurance plans.
For many people, there are potential risks involved.
Background:The cost of medications to patients and doctors has increased in recent years due to the availability of generic drugs for a wide range of conditions, including heart failure, stroke, and nephrotoxicity. We assessed the cost of drugs in the United States for the treatment of patients with chronic kidney disease, including acute, and chronic nephrotoxicity. In an analysis of retail prices of the most commonly prescribed medications in the United States for chronic kidney disease, we found that the retail price for the most commonly prescribed medications was $1,125.00 for a 90-day supply of the most commonly prescribed medications, with a median retail cost of $7,531.00 for a 90-day supply. The retail price for the most commonly prescribed medications was $8,849.00. In general, the retail price for the most commonly prescribed medications increased with increasing duration of use and with increasing number of medications used.
Methods:This analysis evaluated the retail prices of the most commonly prescribed medications for chronic kidney disease in the United States between January 1, 2009, and December 31, 2010. The retail price data were provided as part of an analysis of the data collected from the United States Pharmacopeia. The data were also analyzed to calculate the retail price for the most commonly prescribed medications, as well as a comparison between the retail price and the average retail price of the most commonly prescribed medications. To further investigate the retail price for the most commonly prescribed medications, we analyzed the retail prices for the different drugs. We also evaluated the average retail prices for the different drugs to provide an understanding of the cost of the most commonly prescribed medications. We also evaluated the retail price for the most commonly prescribed drugs, and calculated the average retail price for the different drugs.
Results:Among the drugs covered by the United States Pharmacopeia (the National Institute for Health Care Policy and the Centers for Medicare & Medicaid Services) the retail prices were calculated at the following ranges: $1,125.00 for a 90-day supply of the most commonly prescribed medications, $8,849.00 for a 90-day supply of the most commonly prescribed medications, and $9,849.00 for a 90-day supply of the most commonly prescribed medications. The retail price for the most commonly prescribed medications ranged from $6,531.00 to $7,849.00 for a 90-day supply of the most commonly prescribed medications, and ranged from $7,531.00 to $9,849.00 for a 90-day supply of the most commonly prescribed medications. The retail price for the most commonly prescribed medications ranged from $7,531.00 to $8,849.00 for a 90-day supply of the most commonly prescribed medications, and ranged from $8,849.00 to $9,849.00 for a 90-day supply of the most commonly prescribed medications. The average retail price for the most commonly prescribed medications ranged from $7,849.00 to $9,849.00 for a 90-day supply of the most commonly prescribed medications, and ranged from $7,531.00 to $9,849.00 for a 90-day supply of the most commonly prescribed medications.
Conclusions:The retail price for the most commonly prescribed medications increased with increasing duration of use and with increasing number of medications used.
Introduction to CRESTOR (rosuvastatin, cholesterol-lowering medication)Rosuvastatin is a statin that is the most commonly prescribed medication for the treatment of high cholesterol (C
1) and has been found to be effective in the treatment of patients with coronary heart disease, coronary artery disease, and atheroma formation (rare) and/or the treatment of hypercholesterolemia (rare) and/or aortic aneurysm []. CRESTOR is also used to lower LDL cholesterol, which is one of the primary risk factors for cardiovascular events, including stroke. This medication is also approved for the treatment of high cholesterol and can reduce the risk of hospitalization for cardiovascular disease []. CRESTOR is also used to lower high-density lipoprotein (HDL cholesterol) and to reduce the risk of cardiovascular events in patients with a history of atherosclerotic heart disease [].
Cholesterol is a fatty substance that is formed in the liver after the liver produces cholesterol. It is formed when there is a lack of cholesterol in the blood.
This article was updated in April 2024 to reflect the latest price reductions that have taken effect.
On March 8, 2025, the U. S. Food and Drug Administration approved Crestor, a drug that will be available to patients starting in May.
The drug’s active ingredient is lovastatin, a statin drug, and the active ingredient is the generic version of the brand name drug, Lipitor.
The FDA approved the drug for patients with Type 2 diabetes.
In November 2023, the FDA approved the use of the medication for the prevention of strokes and other serious, potentially fatal, heart-related events, such as unstable angina.
In October 2023, the FDA approved the drug for the prevention of heart failure. The drug was approved to be used in patients with type 2 diabetes who had a diagnosis of heart failure due to symptoms such as shortness of breath and fluid accumulation in the ankles or legs.
The FDA also approved the use of rosuvastatin, the same drug as Crestor and Lipitor.
On March 27, 2025, the FDA approved the use of statins to reduce the risk of heart attacks and strokes, as well as to reduce the risk of strokes and myocardial infarctions.
On November 7, 2023, the FDA approved the use of statins in the prevention of coronary artery disease, as well as in the treatment of heart failure.
The FDA approved the use of the drug in patients with type 2 diabetes who have a diagnosis of diabetes-related disease, such as type 2 diabetes-related hypertension, type 1 diabetes, or type 2 diabetes-related heart failure.
In January 2021, the FDA approved the use of the drug for the prevention of stroke.
The FDA approved the use of the drug in patients with type 2 diabetes who have a diagnosis of diabetes-related disease, such as diabetes-related hypertension, type 1 diabetes, or type 2 diabetes-related heart failure.
On March 5, 2025, the FDA approved the use of the drug for the prevention of heart attack and stroke in patients with type 2 diabetes.
On November 2, 2023, the FDA approved the use of rosuvastatin, the same drug as Crestor and Lipitor.
On March 7, 2025, the FDA approved the use of the drug for the prevention of heart attack and stroke in patients with type 2 diabetes.
On March 28, 2025, the FDA approved the use of rosuvastatin, the same drug as Crestor and Lipitor.
On April 30, 2025, the FDA approved the use of the drug for the prevention of coronary artery disease, as well as in patients with type 2 diabetes.
The FDA approved the use of rosuvastatin, the same drug as Crestor and Lipitor.
On April 29, 2025, the FDA approved the use of rosuvastatin, the same drug as Crestor and Lipitor.
Crestor, containing rosuvastatin, is a widely prescribed statin medication for managing cholesterol levels. It lowers LDL (bad cholesterol) and triglycerides while raising HDL (good cholesterol), reducing the risk of cardiovascular complications such as heart attacks and strokes. It is a trusted choice for individuals at risk of heart disease or those with high cholesterol.
Benefits of Crestor:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
More information about Crestor:
Generic Name: rosuvastatin []; brand or generic valsartanNote:Drug uses rarely required by the U. S. Food and Drug Administration (FDA) cannot be confirmed on active pharmaceutical ingredients (API) websites. API used for laboratory analysis is not FDA-approved. Generic versions are available under other brand names.
See alsoRelated ProductsFor products that contain similar products.For linksWe have two brand names on different websites: Crestor and rosuvastatin. Brand name details and website design are kept on hand for informational andignant purposes. We do not guarantee the accuracy and reliability of any information on the websites listed above.
See also For products that contain similar products.ReferencesFor further information see:
For information about generic versions of drugs, see the “Buy generic from a link” section above.
Show ratings and review from other usersPlease FYI:arma reviews are on here because we may receive product recommendations from people after reading the product information and the reviews posted. We do not guarantee that the feedback we receive is complete and we are able to verify that the reviews state the products are the best. If there is something that we do not agree with, please don't send us anything that is not the experience we expect. We will consider the terms and conditions of any feedback that we receive.
Show ratings based on commentsWe have been buying these products online for over a decade now.
Stade de France Pharmacy